Quince Therapeutics - 54 Year Dividend History | QNCX
Historical dividend payout and yield for Quince Therapeutics (QNCX) since 1971. The current TTM dividend payout for Quince Therapeutics (QNCX) as of January 17, 2025 is $0.00. The current dividend yield for Quince Therapeutics as of January 17, 2025 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.073B |
$0.000B |
|
Quince Therapeutics Inc. is a biopharmaceutical company advancing innovative precision therapeutics targeting debilitating and rare diseases. The company's product pipeline includes NOV004. Quince Therapeutics Inc., formerly known as Cortexyme Inc., is based in Calif.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
